Sound Energy Partners’s Ionis Pharmaceuticals IONS Stock Holding History

Sound Energy Partners’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$1.01M	Buy	+25,000	New	+$1.29M	2.04%	19

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Sound Energy Partners's IONS Position: Q3 2015 in Review

Sound Energy Partners opened a new position in Ionis Pharmaceuticals (IONS) in Q3 2015: 25,000 shares worth $1.01M. The stake represents 2.04% of the portfolio and ranks #19 among its holdings.

314 funds tracked by Wall St. Rank hold IONS as of Q3 2015.

Sound Energy Partners held 25,000 shares of Ionis Pharmaceuticals worth $1.01M as of Q3 2015.
Ionis Pharmaceuticals was a new Sound Energy Partners position in Q3 2015.
Ionis Pharmaceuticals made up 2.04% of Sound Energy Partners's portfolio in Q3 2015, its #19 holding.
314 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2015.

Based on Sound Energy Partners's 13F filing for Q3 2015, filed 13 Nov 2015.